SEGMENT REPORTING (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Net sales	$ 6,555	$ 2,051
Operating loss	(15,092,000)	(18,958,000)
Assets	40,574,000	46,359,000
Accounts receivable, net	357,000	224,000
Inventory	864,000	449,000
Interest expense	544,000	2,472,000
Depreciation and amortization	3,607,000	918,000
Cure Operations [Member]
Net sales	651,000	1,007,000
Operating loss	(8,232,000)	(17,377,000)
Assets	46,491,000	45,376,000
Accounts receivable, net	18,000	131,000
Inventory	243,000	209,000
Interest expense	468,000	2,472,000
Depreciation and amortization	1,295,000	341,000
Sera Labs Operations [Member]
Net sales	6,078,000	1,044,000
Operating loss	(6,860,000)	(1,581,000)
Assets	8,608,000	15,158,000
Accounts receivable, net	339,000	93,000
Inventory	621,000	240,000
Interest expense	86,000	0
Depreciation and amortization	2,312,000	577,000
Eliminations [Member]
Net sales	(174,000)	0
Operating loss	0	0
Assets	14,175,000	14,175,000
Accounts receivable, net	0
Inventory	0
Interest expense	0	0
Depreciation and amortization	$ 0	$ 0